Tau hyperphosphorylation affects Smad 2/3 translocation

Neuroscience

Volumn 163, Issue 2, 2009, Pages 561-570

  Baig, S ^a   van Helmond, Z ^a   Love, S ^a  

^a Institute of Clinical Neurosciences   (United Kingdom)

Author keywords

Alzheimer's disease; cell culture; okadaic acid; oligomeric A ; TGF

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; OKADAIC ACID; SMAD2 PROTEIN; SMAD3 PROTEIN; TAU PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CEREBRAL CORTEX; CYTOPLASM; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOPRECIPITATION; OKADAIC ACID; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; SMAD2 PROTEIN; SMAD3 PROTEIN; TAU PROTEINS;

EID: 69449098018     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.06.045     Document Type: Article

References (67)

1. Abdollah S., Macias-Silva M., Tsukazaki T., Hayashi H., Attisano L., and Wrana J.L. TbetaRI phosphorylation of Smad2 on ser465 and ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 272 (1997) 27678-27685
2. Arendt T., Holzer M., Fruth R., Brückner M.K., and Gärtner U. Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience 69 (1995) 691-698
3. Arendt T., Holzer M., Fruth R., Brückner M.K., and Gärtner U. Phosphorylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol Aging 19 (1998) 3-13
4. Attisano L., and Wrana J.L. Signal transduction by the TGF-beta superfamily. Science 296 (2002) 1646-1647
5. Bennecib M., Gong C.-X., Grundke-Iqbal I., and Iqbal K. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett 485 (2000) 87-93
6. Bennecib M., Gong C.-X., Grundke-Iqbal I., and Iqbal K. Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. FEBS Lett 490 (2001) 15-22
7. Berman D.E., Dall'Armi C., Voronov S.V., McIntire L.B., Zhang H., Moore A.Z., Staniszewski A., Arancio O., and Kim T.W.D.PaoloG. Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat Neurosci 11 (2008) 547-554
8. Bialojan C., and Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 256 (1988) 283-290
9. Bottner M., Krieglstein K., and Unsicker K. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem 75 (2000) 2227-2240
10. Busciglio J., Lorenzo A., Yeh J., and Yankner B.A. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14 (1995) 879-888
11. Caraci F., Battaglia G., Busceti C., Biagioni F., Mastroiacovo F., Bosco P., Drago F., Nicoletti F., Sortino M.A., and Copani A. TGF-beta1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway. Neurobiol Dis 30 (2008) 234-242
12. Chalmers K.A., and Love S. Neurofibrillary tangles may interfere with Smad2/3 signaling in neurons. J Neuropathol Exp Neurol 66 (2007) 158-167
13. Chalmers K.A., and Love S. Phosphorylated Smad2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. J Neuropathol Exp Neurol 66 (2007) 1019-1026
14. Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem 58 (1989) 453-508
15. De Felice F.G., Velasco P.T., Lambert M.P., Viola K., Fernandez S.J., Ferreira S.T., and Klein W.L. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282 (2007) 11590-11601
16. De Felice F.G., Wu D., Lambert M.P., Fernandez S.J., Velasco P.T., Lacor P.N., Bigio E.H., Jerecic J., Acton P.J., Shughrue P.J., Chen-Dodson E., Kinney G.G., and Klein W.L. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Abeta oligomers. Neurobiol Aging 29 (2008) 1334-1347
17. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003) 577-584
18. Dong C., Li Z., Alvarez R., Feng X.-H., and Goldschmidt-Clermont P.J. Microtubule binding to Smads may regulate TGF beta activity. Mol Cell 5 (2000) 27-34
19. Ekinci F.J., Ortiz D., and Shea T.B. Okadaic acid mediates tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel. Brain Res Mol Brain Res 117 (2003) 145-151
20. Ferrari A., Hoerndli F., Baechi T., Nitsch R.M., and Gotz J. Beta-amyloid induces paired helical filament-like tau filaments in tissue culture. J Biol Chem 278 (2003) 40162-40168
21. Ferreira A., Lu Q., Orecchio L., and Kosik K.S. Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol Cell Neurosci 9 (1997) 220-234
22. Flanders K.C., Lippa C.F., Smith T.W., Pollen D.A., and Sporn M.B. Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology 45 (1995) 1561-1569
23. Flanders K.C., Ren R.F., and Lippa C.F. Transforming growth factor-betas in neurodegenerative disease. Prog Neurobiol 54 (1998) 71-85
24. Garzon D.J., and Fahnestock M. Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci 27 (2007) 2628-2635
25. Goedert M., Jakes R., Qi Z., Wang J.H., and Cohen P. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J Neurochem 65 (1995) 2804-2807
26. Gomes F.C.A., Sousa Vde O., and Romao L. Emerging roles for TGF-beta1 in nervous system development. Int J Dev Neurosci 23 (2005) 413-424
27. Gong C.-X., Singh T.J., Grundke-Iqbal I., and Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61 (1993) 921-927
28. Gong C.X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., and Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 275 (2000) 5535-5544
29. Gong C.X., Shaikh S., Wang J.Z., Zaidi T., Grundke-Iqbal I., and Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 65 (1995) 732-738
30. Gray C.W., and Patel A.J. Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta1 and interleukin-1beta in astrocytes. Mol Brain Res 19 (1993) 251-256
31. Hardy J., and Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12 (1991) 383-388
32. Harris K.A., Oyler G.A., Doolittle G.M., Vincent I., Lehman R.A.W., Kincaid R.L., and Billingsley M.L. Okadaic acid induces hyperphosphorylated forms of tau protein in human brain slices. Ann Neurol 33 (1993) 77-87
33. Hill J.J., Callaghan D.A., Ding W., Kelly J.F., and Chakravarthy B.R. Identification of okadaic acid-induced phosphorylation events by a mass spectrometry approach. Biochem Biophys Res Commun 342 (2006) 791-799
34. Kahari V.M., Larjava H., and Uitto J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J Biol Chem 266 (1991) 10608-10615
35. Kim D., Su J., and Cotman C.W. Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment. Brain Res 839 (1999) 253-262
36. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., Lambert M.P., Velasco P.T., Bigio E.H., Finch C.E., Krafft G.A., and Klein W.L. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24 (2004) 10191-10200
37. Lee E.O., Kang J.L., and Chong Y.H. The amyloid-beta peptide suppresses transforming growth factor-b1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells. J Biol Chem 280 (2005) 7845-7853
38. Lee H.G., Ueda M., Zhu X., Perry G., and Smith M.A. Ectopic expression of phospho- Smad 2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?. J Neurosci Res 84 (2006) 1856-1861
39. Liu T., Perry G., Chan H.W., Verdile G., Martins R.N., Smith M.A., and Atwood C.S. Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression. J Neurochem 88 (2004) 554-563
40. Massague J. TGF-beta signal transduction. Annu Rev Biochem 67 (1998) 753-791
41. Metuzals J., Robitaille Y., Houghton S., Gauthier S., and Leblanc R. Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer's disease. J Neurocytol 17 (1988) 827-833
42. Moustakas A., Souchelnytskyi S., and Heldin C.-H. Smad regulation in TGF-beta signal transduction. J Cell Sci 114 (2001) 4359-4369
43. Mudher A.K., Woolley S.T., Perry V.H., and Greene J.R.T. Induction of hyperphosphorylated tau in living slices of rat hippocampal formation and subsequent detection using an ELISA. J Neurosci Methods 88 (1999) 15-25
44. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., Tamaki K., Hanai J., Heldin C.H., Miyazono K., and ten Dijke P. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16 (1997) 5353-5362
45. Pei J.-J., Gong C.-X., An W.-L., Winblad B., Cowburn R.F., Grundke-Iqbal I., and Iqbal K. Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. Am J Pathol 163 (2003) 845-858
46. Peress N.S., and Perillo E. Differential expression of TGF-beta 1, 2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J Neuropathol Exp Neurol 54 (1995) 802-811
47. Prehn J.H., Bindokas V.P., Jordan J., Galindo M.F., Ghadge G.D., Roos R.P., Boise L.H., Thompson C.B., Krajewski S., Reed J.C., and Miller R.J. Protective effect of transforming growth factor-beta1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol 49 (1996) 319-328
48. Rapoport M., Dawson H.N., Binder L.I., Vitek M.P., and Ferreira A. Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A 99 (2002) 6364-6369
49. Ren R.F., and Flanders K.C. Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide. Brain Res 732 (1996) 16-24
50. Ryu J.K., Franciosi S., Sattayaprasert P., Kim S.U., and McLarnon J.G. Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus. Glia 48 (2004) 85-90
51. Saharinen J., Hyytiainen M., Taipale J., and Keski-Oja J. Latent transforming growth factor-beta binding proteins (LTBPs)-structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev 10 (1999) 99-117
52. Saito T., Ishiguro K., Uchida T., Miyamoto E., Kishimoto T., and Hisanaga S.-I. In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons. FEBS Lett 376 (1995) 238-242
53. Shea T.B., and Fischer I. Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules. FEBS Lett 380 (1996) 63-67
54. Sontag E., Luangpirom A., Hladik C., Mudrak I., Ogris E., Speciale S., and White III C.L. Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 63 (2004) 287-301
55. Tanaka T., Zhong J., Iqbal K., Trenkner E., and Grundke-Iqbal I. The regulation of phosphorylation of tau in SY5Y neuroblastoma cells: the role of protein phosphatases. FEBS Lett 426 (1998) 248-254
56. Tian Q., Lin Z.Q., Wang X.C., Chen J., Wang Q., Gong C.X., and Wang J.Z. Injection of okadaic acid into the Meynert nucleus basalis of rat brain induces decreased acetylcholine level and spatial memory deficit. Neuroscience 126 (2004) 277-284
57. Tsukazaki T., Chiang T.A., Davison A.F., Attisano L., and Wrana J.L. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95 (1998) 779-791
58. Ueberham U., Ueberham E., Gruschka H., and Arendt T. Altered subcellular location of phosphorylated Smads in Alzheimer's disease. Eur J Neurosci 24 (2006) 2327-2334
59. Ueberham U., Zobiak B., Ueberham E., Bruckner M.K., Boriss H., and Arendt T. Differentially expressed cortical genes contribute to perivascular deposition in transgenic mice with inducible neuron-specific expression of TGF-beta 1. Int J Dev Neurosci 24 (2006) 177-186
60. van der Wal E.A., Gomez-Pinilla F., and Cotman C.W. Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4 (1993) 69-72
61. Verrecchia F., Chu M.-L., and Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276 (2001) 17058-17062
62. Vogelsberg-Ragaglia V., Schuck T., Trojanowski J.Q., and Lee V.M.Y. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 168 (2001) 402-412
63. 2+-calmodulin-dependent protein kinase II. Mol Cell Biol 20 (2000) 8103-8111
64. Wrana J.L., Attisano L., Wieser R., Ventura F., and Massague J. Mechanism of activation of the TGF-beta receptor. Nature 370 (1994) 341-347
65. Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., Masliah E., and Mucke L. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 7 (2001) 612-618
66. Wyss-Coray T., Masliah E., Mallory M., McConlogue L., Johnson-Wood K., Lin C., and Mucke L. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature 389 (1997) 603-606
67. Yoon S.Y., Choi J.E., Huh J.W., Hwang O., Nam Hong H., and Kim D. Inactivation of GSK-3beta in okadaic acid-induced neurodegeneration: relevance to Alzheimer's disease. Neuroreport 16 (2005) 223-227